| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |